Comparison of hemodynamics between Evolut and Sapien in transcatheter biological valves in dialysis patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030240157

Enrollment

200

Registered

2024-06-13

Start date

2024-01-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic valve stenosis

Interventions

none

Eligibility

Inclusion criteria

Inclusion criteria: Patients on hemodialysis for chronic kidney disease for at least 1 month as of the date of surgery. Have anatomical features suitable for TAVR using both Sapien and Evolut

Exclusion criteria

Exclusion criteria: Patients undergoing peritoneal dialysis for chronic kidney disease. Those who have undergone surgical aortic valve or transcatheter valve implantation.

Design outcomes

Primary

Measure	Time frame
Hemodynamics of biological valves in the first postoperative year (effective valve opening area, blood flow velocity, and mean pressure gradient by echocardiography)	—

Contacts

Public ContactTakeshi Kinoshita

Juntendo University

t.kinoshita.pl@juntendo.ac.jp+81-338133111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026